Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Experts call for significant changes to facilitate the discovery of new treatments.

Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.

A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.

Discovery points toward treatment options beyond insulin injections


By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs

Chronic diseases kill 38 million people per year worldwide; almost three-quarters of those deaths occur in low- and middle-income countries. It’s time to act.

Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

We surveyed 7,000 people in seven countries to find out what they know about multiple sclerosis (MS). Our survey identified several surprising misconceptions.

Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.